Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Celestial Biolabs Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: CELESTIAL | BSE: 532871

₹1.75

up-down-arrow ₹-0.05 (-2.78%)

As on 11-Mar-2020IST

Market cap

info icon

₹5 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue 2.78 8.82 -30.93 -68.16 -70.73
EBIT -6.25 77.78 34.59 -10.49 -161.06
Net Profit -9.38 77.27 34.64 -182.79 -163.73
EPS -9.15 77.27 34.65 -182.79 -163.73
Book Value -- -- -17.07 -10.92 -51.38
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-23Mar-22
EBIT-Margin info -293.67-615.99-302.99-339.72-249.69
Net Margin info ---932.62-308.96----
Return on equity info -11.55-43.97-15.00-18.99-12.22
Return on Capital info -2.48-31.06---3.86-2.47
Return on Assets info -2.24-30.15-4.82-3.38-2.38
Debt to Equity (x) info ----3.404.343.44

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
-3.86
-2.47
--
--
Peer Median
--
18.85
11.60
11.89
12.20
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-15.00

Lower than Peers by 25.85

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
-15.00
-18.99
-12.22
--
--
Peer Median
10.86
14.92
11.46
13.43
10.09
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-4.82

Lower than Peers by 11.56

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
-4.82
-3.38
-2.38
--
--
Peer Median
6.74
9.06
6.44
7.03
5.74
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-302.99

Lower than Peers by 315.68

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
-302.99
-339.72
-249.69
--
--
Peer Median
12.69
14.71
12.37
16.50
13.87
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-308.96

Lower than Peers by 317.82

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
-308.96
-344.64
-277.63
--
--
Peer Median
8.86
8.49
10.02
10.49
8.84
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

0.00

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
0.00
-327.86
-257.15
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-30.93

Lower than Peers by 39.07

Year on year growth in net sales

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
-30.93
14.37
--
--
--
Peer Median
8.14
11.85
9.08
13.45
3.43
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

33.44

Higher than Peers by 16.20

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
33.44
-55.61
--
--
--
Peer Median
17.24
28.00
-3.12
18.27
3.48
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

34.64

Higher than Peers by 17.79

Year on year growth in profit after tax

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
34.64
-41.98
--
--
--
Peer Median
16.85
36.51
-0.85
27.20
-8.07
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

34.65

Higher than Peers by 24.05

Year on year growth in earnings per share

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
34.65
-40.82
--
--
--
Peer Median
10.60
--
-6.82
16.28
-5.54
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
-17.21
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

3.40

Higher than Peers by 3.36

Total debt / Net worth

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
3.40
4.34
3.44
--
--
Peer Median
0.04
0.20
0.15
0.15
0.26
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
1.10
0.91
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.77

Lower than Peers by 0.95

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
0.77
0.79
0.80
--
--
Peer Median
1.72
1.96
2.08
1.89
1.74
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.77

Lower than Peers by 0.41

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
0.77
0.78
0.79
--
--
Peer Median
1.17
1.44
1.58
1.64
1.32
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-50.75

Lower than Peers by 58.61

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
-50.75
-69.05
-8.94
--
--
Peer Median
7.86
8.58
15.41
15.38
12.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

2,738.06

Higher than Peers by 2,712.27

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
2,738.06
2,197.75
2,598.51
--
--
Peer Median
25.79
26.12
22.96
20.72
22.06
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.02

Lower than Peers by 0.65

Sales / Average Total Assets

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
0.02
0.01
0.01
--
--
Peer Median
0.67
0.77
0.65
0.61
0.51
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
8,157.22
9,484.56
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
89.36
120.76
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
1,398.94
1,528.77
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
6,847.64
8,076.55
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
--
--
--
--
Peer Median
39.76
33.48
37.74
60.11
64.03
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.05

Lower than Peers by 4.17

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
0.05
--
--
--
--
Peer Median
4.21
4.21
3.22
3.92
3.87
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
--
--
--
--
--
Peer Median
0.10
0.21
0.57
0.56
0.61
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

1.36

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
1.36
-63.50
-100.93
--
--
Peer Median
--
29.90
28.81
25.94
28.78
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

5

Lower than Peers by 7,379

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-23
Mar-22
Mar-21
Mar-20
Celestial Biolabs
5
--
--
--
--
Peer Median
7,384
2,099
15,272
13,501
14,139
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...